spacer
home > pmps > summer 2018 > smarter technology
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Smarter Technology

Currently, patients with asthma and chronic obstructive pulmonary disease (COPD) rely on metered-dose inhalers (MDIs) and dry powder inhalers (DPIs) to deliver critical medication to their lungs. However, there is room for human error with each and every dose. In fact, an alarming number of patients make mistakes when using their inhalers. Research shows 94% of DPI users and 76% of MDI users do not use their devices properly (1). Furthermore, findings indicate low device competence only continues to rise (2).

The mistakes and misuse can be attributed to a number of factors. In the first place, inhalers – which seem simple on the surface – can be complicated to use. Patients must often rely on their healthcare providers to teach them how to use the devices properly. However, those providers often do not receive proper training themselves on the device’s correct use.

To further complicate matters, research shows a low adherence rate among asthma and COPD patients. One study found only 25% of COPD patients use inhaled medications every day (3). Among asthma patients, up to 70% do not adhere to prescribed medication (4). It goes without saying that, if medication is not delivered correctly, it will be ineffective. When patients are not properly using their inhalers or simply not using them at all, they are not getting the important medication necessary to maintain their health and well-being. Put simply, their health is at risk. MDIs have not changed much in the decades since they were first invented, which is a huge point of frustration for healthcare providers who have long been aware of these problems. Even if they could convince their patients to use their inhalers consistently, the other half of the battle remains. Maureen George, PhD, RN, from the Columbia University Medical Center says, “Adherence alone with bad technique is not going to improve conditions or quality of life for asthma or COPD patients.”

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Excited by the ways technology can improve healthcare outcomes, Sam Van Alstyne is a software engineer who ventured into marketing and has since become passionate about digital health. As the new Products Marketing Leader in 3M’s Drug Delivery Systems Division, he is responsible for connected respiratory programmes.
spacer
Sam Van Alstyne
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BioIVT Acquires UK-based Clinical Trials Laboratory Services

BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Clinical Trials Laboratory Services (CTLS), a donor center and laboratory based in London, UK. CTLS provides dedicated high-quality serum, plasma and blood collection services. It also offers full-service cell processing capabilities on site.
More info >>

White Papers

Crossing the Blood Brain Barrier (BBB): Which Route to Take?

Aptar Pharma

Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >>

 
Industry Events

Outsourcing Clinical Trials Nordics 2018

30-31 October 2018, Copenhagen, Denmark

Following on from the success of the 2017 Outsourcing in Clinical Trials Nordics conference, Arena International is pleased to announce that the event will return for its 6th year in 2018. The 2018 event welcomes biopharmaceutical and medical device companies from across the Nordic region to share knowledge and challenges of outsourcing and clinical operations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement